Louise Connally Strong, MD, Oral History Interview, August 10, 2012
Files
Download Full Interview Transcript (489 KB)
Loading...
Description
Major Topics Covered:
- Personal and educational background
- Overview and history of oncology genetics in the sixties and seventies
- Working with Alfred Knudson
- Research: longitudinal studies of inherited genetics patterns of neuroblastoma, aniridia, and Wilm’s tumor; discovery of the p53 tumor suppressor genes and link to Li-Fraumeni syndrome, survivorship
- Women at MD Anderson
- MD Anderson’s cancer screening program
- Ethics and genetic testing
- MD Anderson growth and cultural change
Publication Date
8-10-2012
Publisher
The Historical Resources Center, Research Medical Library, The University of Texas Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Strong, Louise Connally MD and Rosolowski, Tacey A. PhD, "Louise Connally Strong, MD, Oral History Interview, August 10, 2012" (2012). Interview Sessions. 181.
https://openworks.mdanderson.org/mchv_interviewsessions/181
Conditions Governing Access
Open
About the Interview
About the Interview Subject:
Louise Connally Strong (b. 1944, San Antonio, Texas) came to MD Anderson in 1972 as a Research Associate in the Graduate School of Biomedical Sciences. She is a full professor and Chief of the Section of Clinical Cancer Genetics in the Department of Genetics with joint positions in the Graduate School of Biomedical Sciences, in MD Anderson’s Department of Pediatrics/Biology and in Cancer Genetics in Breast Medical Oncology.
Dr. Strong has conducted longitudinal studies of inherited genetics patterns of neuroblastoma, aniridia, and Wilm’s tumor. She is best known for her her discovery of the p53 tumor suppressor genes and its link to Li-Fraumeni syndrome.
She has served ad interim Co-Director for Human Cancer Genetics Program Clinical Cancer Genetics, as Deputy Department Chair, Department of Experimental Pediatrics in the Division of Pediatrics, and as Director for Basic Research, Division of Pediatrics. Outside the institution, she served on NCI Data Evaluation Human Risk Assessment Project and President of American Association for Cancer Research (’96 – ’97). She was appointed by President Ronald Reagan to two terms on National Cancer Advisory Board.